a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer
NCT04790539
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
71
Enrollment
OTHER
Sponsor class
Conditions
Extensive Stage Small Cell Lung Cancer
Interventions
DRUG:
SHR-1210
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China